Dr. Aleš Rozman is a distinguished Slovenian medical professional renowned for his extensive experience and expertise in the fields of interventional pulmonology and healthcare management. He completed his medical education at the University of Ljubljana, Slovenia, in the year 2000. Throughout his career, he held key positions such as Head of the Respiratory Endoscopy Department and Interventional Pulmonology Department at the University Clinic Golnik, as well as the CEO of the same clinic.
With over two decades of active involvement in interventional pulmonology, Aleš Rozman’s primary focus has always been advancing medical knowledge and enhancing patient care. His skillset spans across a broad spectrum, ranging from interventional pulmonology and intensive care to medical oncology. His research contributions encompass interventional pulmonology, lung cancer, interstitial lung diseases, and obstructive lung diseases. Additionally, he has taken on the role of an assistant professor at the University of Ljubljana and is dedicated to mentoring students, PhD candidates, and medical residents. Aleš is also recognized as a distinguished faculty member and a sought-after speaker at international courses and congresses dedicated to bronchology and interventional pulmonology. Aleš’s dedication to the medical community extends beyond his clinical work. He has actively participated in various appointments and boards, serving as the Head of the Slovenian Medical Council for two terms, and as a member of the National Advisory Board for COVID-19. In these roles, he has made significant contributions to important healthcare decisions in Slovenia.
Aleš Rozman
Position: Respiratory Consultant and Pleural Lead, Norfolk and Norwich University Hospitals
Specialties: Respiratory Medicine
Sub-Speciality: Pleural disease, lung cancer
Special Clinical Interests: Pleural disease including medical thoracoscopy, indwelling pleural catheters, malignant pleural disease, pleural infection and pneumothorax including ambulatory management.
Research Interests: Malignant pleural disease, with a particular focus on improving patient outcomes. Current research work involves prediction of rate of pleural fluid reaccumulation, patient reported outcome measure and diagnosis and management of indwelling pleural catheter infections. I am also interested in bacteriophage treatment for Pseudomonas colonisation in patients with bronchiectasis.
Current Membership of Professional, National and Regional Bodies: Committee member of UK Pleural Society responsible for organising the annual research conference; British Thoracic Society, NIHR RfPB committee member.
Universities and Degrees: MA (Cantab), MBChB (University of Oxford), DPhil (University of Oxford).
Eleanor Mishra
Education
Classical high school Diploma : july 1980 mark 60 out of 60 Liceo Classico Ugo Foscolo, Pavia, Italy
Degree in Medicine and Surgery 18/07/1986 mark 110 out of 110 Magna cum Laude, University of Pavia, Pavia, Italy.
Specialization in Onclology University of Pavia, Pavia, Italy obtained on 04/10/1993 mark: 50 out of 50, cum Laude.
Diploma of Doctorate (PhD) in Pharmacology and Toxicology, field : Immunopharmacology University of Turin , Turin Italy obtained on 20/10/1995.
Courses
Course title: “Current issues in Epidemiology: the prevention and control of Chronic Diseases” Cambridge 6-16/07/1993
International Experiences:
During PhD attendance of Theodor Kocher Institute, University of Bern(Bern, Switzerland) in order to analyze the role of chemokines in interstitial diseases.
Voluntary stage at Universitätspital di Zurigo 20-25/03/2000
Actual position:
Associate professor of Respiratory Diseases, Faculty of Medicine and Surgery, at the University of Padova, & AOPD Padova Italy since 1/03/2024.
Actual Working address : UOC Fisiopatologia Respiratoria AOPD, Padova, Medical Responsible for Lung transplant Follow up at AOPD.
Previous academic position:
Researcher in Respiratory Diseases, Faculty of Medicine and Surgery, at the University of Pavia, Pavia Italy from 01/11/200dal 01/11/1992 to 31/10/2001. 1/11/20011-28/02/2024 Associate professor of Respiratory Diseases University of Pavia The convention with Respiratory Disease Unit at San Matteo Foundation Started on 1/11/199 7 until 28/02/2024. since 01/11/2001.
Teaching activity
Since 1/11/2001 to today F. Meloni has been responsible, yearly, of several University courses of Respiratory Disease within the degree in Medicine and Surgery in Italian and English courses, and within the degree in Nursing, Perfusion Technician, Physical Therapist,Motor Sciences.
Federica Meloni
Dr. Guido Marchi is a Pulmonologist at Pisa University Hospital, Italy, with dual Italian-Canadian citizenship.
He serves as Early Career Member Representative for Assembly 14 (Clinical Techniques, Imaging and Endoscopy) of the European Respiratory Society (ERS, 2025–2028), and for the ERS Clinical Research Collaboration (CRC) Working Group and ERS Monograph.
He is National Secretary of the Imaging Study Group of the Italian Respiratory Society (SIP/IRS), Scientific Director of the Italian Congress of Imaging in Pulmonology and author of multiple indexed peer-reviewed publications.
Dr. Marchi is also a member of the American Thoracic Society (ATS) Documents Development and Implementation Committee and the new ATS Task Force on Artificial Intelligence.
He holds second-level Master’s degrees in Bronchoscopy and Interventional Pulmonology from the University of Florence and in Methodology of Research and Clinical Experimentation from the University of Pisa.
He is active in professional societies including ERS, ATS, WABIP, SIP-IRS, SIET, and the Italian Society of Artificial Intelligence in Medicine (SIIAM).
His clinical and research expertise includes imaging, thoracic ultrasound, pleural diseases, interventional pulmonology, obstructive airway diseases, drug-induced interstitial lung diseases, and AI integration in respiratory medicine, applied to optimize patient care and scientific dissemination.
Guido Marchi
Kelvin Lau qualified from the University of Oxford and was awarded a doctorate for his research into tumour targeting. He was appointed as the first consultant thoracic surgeon at Barts to set up the thoracic surgery service. Together with his colleagues, they built a large and innovative programme of robotic surgery, segmentectomy, peripheral bronchoscopy, mesothelioma surgery and lung volume reduction.
In November 2015 he led the first team in Europe to successfully use the latest version of navigation bronchoscopy, and went on to do the first in the world endobronchial microwave ablation of lung tumour in February 2018. He started using Ion robotic bronchoscopy in June 2023 as part of a clinical trial to evaluate the diagnostic outcomes when combining robotic bronchoscopy with cone beam CT.
His interests include hybrid theatre, image-guidance for thoracic surgery and advanced guided bronchoscopy for therapy such as ablation. He is principal investigator for the NAVIGATE, NAVABLATE, MARS2, RAMON and Ion trials.
Kelvin Lau
Marko Topalović, PhD, serves as the Chief AI Officer at Clario, a leading company specializing in technology and data solutions for clinical trials. Formerly, Marko was a CEO and founder of ArtiQ, a respiratory AI-diagnostics company. Prior to that, at the KU Leuven, Marko worked as a postdoc researcher on inventing AI-based algorithms for respiratory diagnostics and clinical trials.
He obtained a PhD degree on the topic “Artificial intelligence for pulmonary function tests” at the KU Leuven. His scientific work has contributed to many peer-reviewed publications and numerous conference presentations. Additionally, he received several international awards.
Marko Topalović
Michelle is an experienced physiotherapist specializing in respiratory support and airway clearance for patients with sleep and breathing problems. She is a Consultant Physiotherapist at both the Royal Brompton and The National Hospital for Neurology and Neurosurgery. Michelle completed her PhD in 2006 and has published extensively in the areas of initiation and telehealth of patients on ventilation, along with airway clearance strategies for patients with neuromuscular disease ad neuro-disability. She has delivered over 130 keynote lectures internationally, and chaired sessions at major respiratory conferences. Her expertise spans, sleep, invasive and non-invasive ventilation, airway clearance techniques, and transitional care for complex patients. She also has a part-time role as Head of Education and Research at Breas Medical, where she leads global education initiatives, develops clinical strategies, and advises on research and device innovation. Her work includes creating non-commercial educational platforms, mentoring, and collaborating with key opinion leaders worldwide.
Michelle Chatwin
Vicky Gerovasili
Receba todas as actualizações do congresso.
Obrigado pela sua inscrição nas Newsletter. Irá receber as atualizações no seu email.
Encontramo-nos no Porto.
Obrigado pela sua inscrição nas Newsletter. Irá receber as atualizações no seu email.
Encontramo-nos no Porto.
Av. Antunes Guimarães, 554
4100–074 Porto
+351 226 165 450